News & Updates

Though relatively rare, medication-related osteonecrosis of the jaw (MRONJ) can nevertheless occur after denosumab treatment, even in the absence of invasive dental treatment, reports a recent study.

Use of a fixed-dose combination therapy or a polypill effectively lowers cardiovascular risk factors but falls short of producing significant reductions in mortality, according to a systematic review and meta-analysis.

In patients on long-term hydroxychloroquine (HCQ) therapy, rapid macular thinning appears to alert a potential retinal damage related to HCQ treatment, a study has found.

Inappropriate prescription practices and polypharmacy remain a burden in patients treated with immune checkpoint inhibitors (ICIs), a study has found.

All urate-lowering therapies work to reduce uric acid concentrations in patients with chronic kidney disease (CKD), although it is unclear whether this benefit extends to those with renal disease, according to the results of a meta-analysis.

Treatment with either high- or low-dose lebrikizumab reduces the rate of exacerbation in patients with uncontrolled asthma, according to the ACOUSTICS* trial presented at ATS 2022.

Pharmaceutical workers who serve in healthcare settings are in danger of antineoplastic drug contamination not just inside the compounding room but also in adjacent rooms, reveals a study.